Latest News
25-Sep-2023 Concord Biotech’s Niche Strengths Seen Buoying Earnings: Analysts
22-Sep-2023 Nirma to Buy 75% in Glenmark’s API Arm for ₹5,615 cr
21-Sep-2023 Manipal Buys 84% Stake in AMRI Hospitals
21-Sep-2023 Notification on Pharma Quality Norms Likely Soon
19-Sep-2023 New Covid Variant Pirola Not Yet Detected in India
  more...
Latest Reports
Sep-23 US generics - turning the tide? - Motilal Oswal  
Sep-23 Sharp MoM uptick in chemicals - Centrum Research  
Sep-23 Healthy uptick in pricing - IDBI Capital  
Sep-23 Small volume, high margin products key for success - Prabhudas Lilladher  
Aug-23 Some respite in pricing pressures - IDBI Capital  
  more...

Quarterly Summary June-2023
Desc Current Previous Per.Chg
Sales 58149.3 53665.5 8.4
Otherincome 1728.9 1974.0 -12.4
Expense 45238.1 43754.2 3.4
RawMaterial 19032.2 18781.5 1.3
StaffCost 8732.0 8175.8 6.8
ExciseDuty 58.5 64.2 -8.8
OtherExp 13516.0 12509.9 8.0
Interest 1060.2 702.0 51.0
GrossProfit 14454.3 11753.1 23.0
Depreciation 2682.3 2567.0 4.5
Tax 2829.5 2107.4 34.3
NetProfit 8716.8 7677.5 13.5
Total.Comp 179 -- --
Source: ETIG Database

Sectoral Companies As on 22 Sep 2023
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 271504.79
Divi's Lab 98386.39
Cipla 95794.22
Dr.Reddy's 92001.69
Mankind Phar 70169.10
Torrent Phar 62652.01
Zydus Life 60971.57
Aurobindo Ph 50744.80
Lupin 49937.72
Abbott (I) 47943.83
Alkem Labora 42377.49
Biocon 31689.84
Syngene Intl 31027.90
  click here for the complete list